leadf
logo-loader
viewArgentex

Argentex co-CEO reports significant increase in underlying earnings in first year as listed company

Argentex Group PLC's (LON:AGFX) co-CEO Carl Jani tells Proactive London's Andrew Scott they saw a significant increase in underlying earnings in its first year as a listed company. Profit before tax in the year to the end of March 2020, shot up to £10.2mln from £2.1mln the previous year on revenue that rose to £29.0mln from £21.9mln the year before as foreign exchange passing through the Argentex system topped £12bn – up 32.3% year-on-year.

Quick facts: Argentex

Price: 118.5 GBX

AIM:AGFX
Market: AIM
Market Cap: £134.15 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Argentex named herein, including the promotion by the Company of Argentex in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Mountain Valley MD gets approval for COVID-19 clearance trial in Level 4 Bio...

Mountain Valley MD (CSE: MVMD) CEO Dennis Hancock and Director of Life Sciences Mike Farber joined Steve Darling with news the company will be conducting a Bio-Safety Level 4 lab study of COVID-19 viral clearance to prove out the Company’s solubilized Ivermectin technology versus commercially...

3 hours, 33 minutes ago

2 min read